FDA Announces Very Broad Distribution, "Usefulness" Assessment of Pharmacy-Distributed Patient Leaflets

A long-awaited national study of the distribution and “usefulness” of pharmacy-distributed patient medicine leaflets, whose results were released today by the FDA, found that 89% of patients received leaflets with their prescriptions. This exceeds the 75% target for the year 2000 that was set by a 1996 law. The study also had two panels of reviewers assess the quality of the leaflets, an “expert” panel and a consumer panel. While consumers were critical of leaflets' legibility, they were more positive about their comprehensiveness and usefulness, the researchers found. The study was conducted by the University of Wisconsin-Madison, School of Pharmacy.